|
|
Volumn 1, Issue 3, 2001, Pages 277-285
|
|
Immunologic therapy for relapsing-remitting multiple sclerosis.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
AZATHIOPRINE;
BETA INTERFERON;
BETA1A INTERFERON;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
GLATIRAMER;
IMMUNOGLOBULIN;
IMMUNOLOGICAL ADJUVANT;
IMMUNOSUPPRESSIVE AGENT;
INTERFERON BETA SERINE;
INTERFERON BETA-1B;
METHOTREXATE;
MITOXANTRONE;
PEPTIDE;
STEROID;
AUTOIMMUNE DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DISEASE COURSE;
DRUG ADMINISTRATION;
FORECASTING;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
LONGITUDINAL STUDY;
MULTIPLE SCLEROSIS;
PLASMAPHERESIS;
REVIEW;
TREATMENT OUTCOME;
ADJUVANTS, IMMUNOLOGIC;
ADRENAL CORTEX HORMONES;
ANTI-INFLAMMATORY AGENTS;
AUTOIMMUNE DISEASES;
AZATHIOPRINE;
CLINICAL TRIALS;
CYCLOPHOSPHAMIDE;
DISEASE PROGRESSION;
DRUG ADMINISTRATION SCHEDULE;
FORECASTING;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOSUPPRESSIVE AGENTS;
IMMUNOTHERAPY;
INTERFERON-BETA;
LONGITUDINAL STUDIES;
METHOTREXATE;
MITOXANTRONE;
MULTIPLE SCLEROSIS;
PEPTIDES;
PLASMA EXCHANGE;
PLASMAPHERESIS;
STEROIDS;
TREATMENT OUTCOME;
|
|
EID: 0035352991
PISSN: 15284042
EISSN: None
Source Type: Journal
DOI: 10.1007/s11910-001-0031-9 Document Type: Review |
|
Times cited : (8)
|
|
References (43)
|
